Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CSTL
CASTLE BIOSCIENCES, INC.
NASDAQ
$32.91
▲ UP 0.80% (0.26)

KEY STATISTICS

Market Cap$1.00 B
52w High$44.28
52w Low$17.72
Dividend Yield—
Frequency—
P/E-49.86
Volume187.72K
Shares Out.30.55M

COMPANY

LEADERSHIP

Derek J. Maetzold
CHIEF EXECUTIVE
Derek J. Maetzold

COMPENSATION 2026

Salary$751,350
Stock Awards$4,977,208
Incentive Plan Pay$1,036,863
All Other Comp.$21,350
Total$6,786,771

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 25, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,002

PRICE TARGET

Target High$44.00
Target Low$35.00
Target Median$40.00
Target Consensus$39.00

UPCOMING EARNINGS

DateNov 2, 2026
DayMonday
Rev. Est.$92.13M
NOV
2
MON

PRICE

$32.91 ▲ UP 0.80% (+$0.26)
$32.00$32.40$32.80$33.209:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM32.91

About Castle Biosciences, Inc.

https://castlebiosciences.com ↗

Castle Biosciences, Inc. is a Texas-based diagnostics company specializing in prognostic and diagnostic tests, like DecisionDx-Melanoma and DecisionDx-UM, to assess metastasis risk in dermatological cancers.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT CASTLE BIOSCIENCES, INC. IS KNOWN FOR

TissueCypher Barrett's Esophagus test
TissueCypher Barrett's Esophagus test

Castle Biosciences' prognostic test predicts the development of high-grade dysplasia or esophageal cancer in Barrett's Esophagus patients, serving as a key growth driver with increasing test reports.

COMPETITORS

COMPETITOR
GH COMPARE
LUCD COMPARE
MYGN COMPARE
NEO COMPARE
VCYT COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Dermatologic$48.52M $48.59M ▲$41.1M ▼$48.7M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
140
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.00% · 852.7K
IWM
0.03% · 769.2K
BSVO
0.19% · 145.8K
SCHA
0.02% · 142.9K
XHS
1.60% · 109.0K
DFMC
0.04% · 107.6K
FESM
0.05% · 95.2K
AVSC
0.06% · 58.1K
PRFZ
0.04% · 37.3K
GSSC
0.10% · 32.1K
ISMD
0.28% · 29.3K
XRSU.L
0.03% · 26.7K
NUSC
0.07% · 26.2K
HAPS
0.49% · 26.1K
ETHO
0.39% · 23.0K
JPSE
0.09% · 15.8K
RSSL
0.03% · 14.4K
WSCSRI.SW
0.03% · 8.5K
ROSC
0.26% · 4.3K
SQLV
0.28% · 3.5K
RTWO.L
0.04% · 2.7K
URTY
0.01% · 1.2K
TILT
0.00% · 948
TXS
0.07% · 835
QSML
0.10% · 389
RESM
0.05% · 85

INSTITUTIONAL OWNERSHIP

SHARES OWNED
68.43%
HOLDERS
273
TOP 12 OF 273 · RANKED BY POSITION SIZE
Blackrock, Inc.
3.3M sh · $78.51M
Blackrock Inc.
3.0M sh · $66.29M
Rtw Investments, LP
2.8M sh · $66.26M
Vanguard Group Inc
2.2M sh · $85.57M
Principal Financial Group Inc
1.8M sh · $70.32M
Portolan Capital Management, LLC
1.7M sh · $67.28M
Dimensional Fund Advisors LP
1.5M sh · $33.56M
Summit Partners Public Asset Management, LLC
1.1M sh · $41.18M
Nuveen, LLC
957.1K sh · $21.79M
Acadian Asset Management LLC
918.7K sh · $21.9M
Braidwell LP
822.7K sh · $18.73M
State Street Corp
822.1K sh · $19.63M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Josh Gottheimer
Josh Gottheimer
Sale (Partial)
2022-03-15
 Josh S. Gottheimer
Josh S. Gottheimer
Sale (Partial)
2022-03-15
 Gilbert Cisneros
Gilbert Cisneros
Purchase
2020-12-23
 Gilbert Ray Cisneros
Gilbert Ray Cisneros
Purchase
2020-12-23

INSIDER TRADES

★
OFFICER: CHIEF OPERATING OFFICER
Oelschlager Kristen M
Purchase · 4.2K shares
2026-09-01
★
OFFICER: CHIEF OPERATING OFFICER
Oelschlager Kristen M
Sale · 4.0K shares
2026-09-01
★
OFFICER: CHIEF OPERATING OFFICER
Oelschlager Kristen M
Sale · 200 shares
2026-09-01
★
OFFICER: CHIEF OPERATING OFFICER
Oelschlager Kristen M
Sale · 4.2K shares
2026-09-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
OUTPERFORM 1
5 GRADES IN THE LAST 12 MONTHS
BTIG BUY Baird OUTPERFORM Canaccord Genuity BUY Guggenheim BUY Lake Street BUY

SECTORS PEERS

PEERPRICE
CDNA$49.93COMPARE
VIR$11.55COMPARE
PSNL$17.09COMPARE
AMN$33.66COMPARE
GERN$1.52COMPARE
FLGT$19.55COMPARE
EVH$4.26COMPARE
EMBC$5.89COMPARE